Trial Profile
A Single-Center, Randomized, Double-Blind, Parallel, Pilot Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Eperisone/pelubiprofen (Primary) ; Pelubiprofen
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Daewon Pharmaceutical
- 12 Feb 2018 New trial record